Regeneron Pharmaceuticals (REGN), Universal Health Services (UHS), Emerson Electric Company (EMR) are the highest sales growth and return on equity stocks on this list.

Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?

1. Regeneron Pharmaceuticals (REGN)

36.4% sales growth and 31.77% return on equity

Regeneron Pharmaceuticals, Inc., a biopharmaceutical company, discovers, invents, develops, manufactures, and commercializes medicines for treating various medical conditions worldwide.

Regeneron Pharmaceuticals’s sales growth this year is anticipated to be 42.2% and a negative 7.5% for next year.

Year-on-year quarterly revenue growth grew by 20%, now sitting on 8.31B for the twelve trailing months.

Volume

Today’s last reported volume for Regeneron Pharmaceuticals is 758043 which is 7.98% below its average volume of 823775.

Regeneron Pharmaceuticals’s sales growth is a negative 0% for the ongoing quarter and 36.4% for the next. The company’s growth estimates for the present quarter and the next is 144.7% and 21.2%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 31.77%.

Volatility

Regeneron Pharmaceuticals’s last day, last week, and last month’s current volatility was 1.69%, 0.80%, and 0.88%, respectively.

Regeneron Pharmaceuticals’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 3.37% (day), 2.44% (last week), and 2.31% (last month), respectively.

Regeneron Pharmaceuticals’s Stock Yearly Top and Bottom Value

Regeneron Pharmaceuticals’s stock is valued at $521.85 at 08:22 EST, way below its 52-week high of $664.64 and way above its 52-week low of $441.00.

Regeneron Pharmaceuticals’s Moving Average

Regeneron Pharmaceuticals’s worth is higher than its 50-day moving average of $501.26 and above its 200-day moving average of $492.09.

2. Universal Health Services (UHS)

11% sales growth and 16.82% return on equity

Universal Health Services, Inc., through its subsidiaries, owns and operates acute care hospitals, outpatient facilities, and behavioral health care facilities.

Universal Health Services’s sales growth this year is anticipated to be 6.8% and 4.2% for next year.

Year-on-year quarterly revenue growth grew by 6.5%, now sitting on 11.74B for the twelve trailing months.

Volume

Today’s last reported volume for Universal Health Services is 747221 which is 20.98% above its average volume of 617626.

Universal Health Services’s sales growth is a negative 0% for the current quarter and 11% for the next. The company’s growth estimates for the present quarter and the next is a negative 8.9% and negative -8.3%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 16.82%.

Volatility

Universal Health Services’s last day, last week, and last month’s current volatility was 0.64%, 0.40%, and 0.83%, respectively.

Universal Health Services’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 2.39% (day), 1.64% (last week), and 1.99% (last month), respectively.

Universal Health Services’s Stock Yearly Top and Bottom Value

Universal Health Services’s stock is valued at $158.98 at 08:22 EST, below its 52-week high of $162.51 and way higher than its 52-week low of $86.67.

Universal Health Services’s Moving Average

Universal Health Services’s worth is above its 50-day moving average of $154.25 and way above its 200-day moving average of $138.94.

3. Emerson Electric Company (EMR)

9.3% sales growth and 25.77% return on equity

Emerson Electric Co., a technology and engineering company, provides solutions to industrial, commercial, and consumer markets worldwide.

Emerson Electric Company’s sales growth this year is expected to be 8.1% and 6% for next year.

Year-on-year quarterly revenue growth grew by 6.5%, now sitting on 17.06B for the twelve trailing months.

Volume

Today’s last reported volume for Emerson Electric Company is 1770140 which is 36.85% below its average volume of 2803220.

Emerson Electric Company’s sales growth is a negative 0% for the current quarter and 9.3% for the next. The company’s growth estimates for the present quarter and the next is 21.2% and 6.4%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 25.77%.

Volatility

Emerson Electric Company’s last day, last week, and last month’s current volatility was 0.11%, 0.30%, and 0.87%, respectively.

Emerson Electric Company’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.23% (day), 1.38% (last week), and 1.77% (last month), respectively.

Emerson Electric Company’s Stock Yearly Top and Bottom Value

Emerson Electric Company’s stock is valued at $98.21 at 08:22 EST, below its 52-week high of $98.74 and way above its 52-week low of $58.67.

Emerson Electric Company’s Moving Average

Emerson Electric Company’s worth is higher than its 50-day moving average of $93.73 and way higher than its 200-day moving average of $86.99.

4. Silgan Holdings (SLGN)

6.2% sales growth and 28.25% return on equity

Silgan Holdings Inc., together with its subsidiaries, manufactures and sells rigid packaging for consumer goods products in North America, Europe, and internationally.

Silgan Holdings’s sales growth this year is expected to be 9.2% and 2.3% for next year.

Year-on-year quarterly revenue growth grew by 20.2%, now sitting on 5.13B for the twelve trailing months.

Volume

Today’s last reported volume for Silgan Holdings is 274774 which is 18.27% below its average volume of 336210.

Silgan Holdings’s sales growth for the next quarter is 6.2%. The company’s growth estimates for the current quarter and the next is a negative 2.4% and 4.8%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 28.25%.

Volatility

Silgan Holdings’s last day, last week, and last month’s current volatility was 0.12%, 0.95%, and 1.09%, respectively.

Silgan Holdings’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.35% (day), 1.72% (last week), and 2.09% (last month), respectively.

Silgan Holdings’s Stock Yearly Top and Bottom Value

Silgan Holdings’s stock is valued at $41.59 at 08:22 EST, below its 52-week high of $44.55 and way above its 52-week low of $30.68.

Silgan Holdings’s Moving Average

Silgan Holdings’s value is below its 50-day moving average of $42.82 and higher than its 200-day moving average of $39.61.

LEAVE A REPLY

Please enter your comment!
Please enter your name here